UnknownNCT02938156
UK - EHL Outcomes Registry
Studying Hemophilia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Royal Free Hospital NHS Foundation Trust
- Principal Investigator
- Pratima ChowdaryRoyal Free Hospitals NHS Foundation Trust
- Enrollment
- 500 enrolled
- Eligibility
- MALE
- Timeline
- 2016 – 2019
Study locations (21)
- Basingstoke and North Hampshire Hospital, Basingstoke, United Kingdom
- Birmingham Women and Childrens, Birmingham, United Kingdom
- Queen Elizabeth Hospital, Birmingham, United Kingdom
- University Hospital Bristol, Bristol, United Kingdom
- Kent & Canterbury Hospital, Canterbury, United Kingdom
- University Hospital of Wales, Cardiff, United Kingdom
- University of Coventry & Warwickshire, Coventry, United Kingdom
- Glasgow Royal Hospital for Children, Glasgow, United Kingdom
- Royal Infirmary, Glasgow, United Kingdom
- Lincoln County Hospital, Lincoln, United Kingdom
- Liverpool University Hospital, Liverpool, United Kingdom
- Royal Free Hospital NHS Foundation Trust, London, United Kingdom
- Great Ormond Street Hospital, London, United Kingdom
- Hammersmith Hospital, London, United Kingdom
- St George's Hospital, London, United Kingdom
- +6 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02938156 on ClinicalTrials.govOther trials for Hemophilia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT07406139PCC Treatment for Hemophilia Patients With Inhibitor（2022PCC-A）Institute of Hematology & Blood Diseases Hospital, China
- RECRUITINGPHASE3NCT04563520SAFE Study: Safety of aPCC Following Emicizumab ProphylaxisEmory University
- RECRUITINGNCT07101926Monitoring of Anti-TFPI in HemophiliaHospices Civils de Lyon
- RECRUITINGPHASE4NCT06941870Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial HypertrophySanofi
- RECRUITINGNCT07314983Long-term Anticoagulation in a Patient With Severe Hemophilia AUniversity Hospital, Strasbourg, France
- RECRUITINGPHASE4NCT06940830Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog AlfaSwedish Orphan Biovitrum
- RECRUITINGPHASE1NCT06703606A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.Pfizer
- RECRUITINGPHASE3NCT06833983To Evaluate the Clinical Study of GS1191-0445 Injection in the Treatment of Hemophilia AGritgen Therapeutics Co., Ltd.